Advertisement
News
Advertisement

Women's health company lands $21M Series D for uterine fibroid ablation

Wed, 02/20/2013 - 1:38pm
Mass Device

California company Gynesonics lands a $21 million Series D funding round in support of its VizAblate ultrasound-guided uterine fibroid ablation system.

Gynesonics logo

Women's health devices maker Gynesonics landed $21 million in new financing in supports of its ultrasound-guided uterine fibroid ablation system, the company announced today.

The California company plans to use the funds to further clinical and commercial progress for its VizAblate system, a minimally invasive method for treating uterine fibroids and an alternative to hysterectomy.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading